Home › Non-Hodgkinlymfoom › Ohio › Columbus
Non-Hodgkinlymfoom klinische studies in Columbus, OH
18 studies voor Non-Hodgkinlymfoom zoeken deelnemers op locaties in en rond Columbus (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
RekruterenFase 3
- Study Site 104, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
RekruterenFase 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruterenFase 1
- The Ohio State University (OSU), Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruterenFase 2
- Research Site, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- The Ohio State University Wexner Medical Center James Cancer, Columbus
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RekruterenFase 1
- The Ohio state University, Columbus
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Nationwide Children's Hospital, Columbus
- The Arthur G. James Cancer Hospital/The Ohio State University Medical Center, Columbus
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
RekruterenFase 1
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruterenFase 1
- The Ohio State University, Columbus
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
RekruterenFase 1
- The Ohio State University, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Memorial Hospital, Marysville · 27 mijl verwijderd
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
RekruterenFase 4
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
RekruterenFase 4
- Ohio State University Comprehensive Cancer Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruterenFase 1
- The Ohio State University - The James Cancer Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruterenFase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
RekruterenFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Non-Hodgkinlymfoom studies in andere steden
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Chicago, IL18 studies
- Atlanta, GA18 studies
- Milwaukee, WI18 studies
- Dallas, TX17 studies
- Seattle, WA16 studies
Andere studies in Columbus
- Niet-kleincellige longkanker57 studies
- Borstkanker40 studies
- Eierstokkanker39 studies
- Kanker (alle vormen)38 studies
- Longkanker37 studies
- Acute myeloïde leukemie35 studies
- Chronische lymfatische leukemie28 studies
- Metastatische kanker27 studies
- Endometriumkanker25 studies
- Prostaatkanker24 studies
- Multipel myeloom24 studies
- Colorectale kanker24 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.